Literature DB >> 29752000

Noncompliance of patients with driving restrictions due to uncontrolled epilepsy.

Laurent M Willems1, Philipp S Reif2, Susanne Knake3, Hajo M Hamer4, Constantin Willems5, Günter Krämer6, Felix Rosenow7, Adam Strzelczyk7.   

Abstract

Epilepsies are a common and chronic neurological disorder characterized by sustained risk of recurrent seizures. Because of paroxysmal and often unpredictable occurrence of seizures, patients with uncontrolled epilepsy are subject to disease-specific restrictions in daily life, such as their career choice or specific work limitations. According to German law and many other European and international guidelines, driving is strictly prohibited in patients with uncontrolled epilepsy so as to increase active and passive safety in public road traffic. Nevertheless, a significant percentage of patients probably do not comply with these legal restrictions and drive on a regular basis. For this study, we analyzed a representative German cohort with 302 patients (mean age: 45.0 years ± 16.4; 48% male) with established epilepsy to identify the number of patients driving without permission. Overall, 58.6% (n = 177) of patients had a driving license, 71.1% (n = 69/97) of patients were in seizure remission, and 52.7% (n = 108/205) of patients had uncontrolled epilepsy. Among patients in seizure remission, 54.6% (n = 53/97) reported regular driving while, among patients with uncontrolled epilepsy, 15.1% (n = 31/205) reported driving on a regular basis. No patient in the cohort stated driving without a valid license. Permanent employment, freelance work, the absence of a relevant disability, and living alone were identified as significant risk factors, which underlines the already existing evidence for the importance of a possible restricted access to the labor market as motive for disregarding legal driving restrictions. In our opinion, specialized and generally available social counseling with a special focus on vocational and career guidance is urgently needed to improve compliance with epilepsy-caused driving restrictions and the underlying reasons for violating these rules. In addition, more effort has to be spent on improving diagnostics and treatment of epilepsy to reduce the number of patients with uncontrolled seizures. Comprehensive introduction of self-driving vehicles may also help to improve mobility of patients with refractory epilepsy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Driving license; Driving permission; Epilepsy; Noncompliance; Seizure

Mesh:

Year:  2018        PMID: 29752000     DOI: 10.1016/j.yebeh.2018.04.008

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  [Acceptance, demand, reasons for consultation and outcome of counseling on epilepsy in Hesse and Lower Franconia].

Authors:  Jacqueline M Kondziela; Juliane Schulz; Bernhard Brunst; Simone Fuchs; Stefan Gerlinger; Birgit Neif; Henrike Staab-Kupke; Silke Vasileiadis; Peter Brodisch; Susanne Knake; Tobias Kniess; Bernd Schade; Bernd A Neubauer; Felix Rosenow; Susanne Schubert-Bast; Adam Strzelczyk; Laurent M Willems
Journal:  Nervenarzt       Date:  2019-08       Impact factor: 1.214

2.  Decoding health status transitions of over 200 000 patients with traumatic brain injury from preceding injury to the injury event.

Authors:  Tatyana Mollayeva; Andrew Tran; Vincy Chan; Angela Colantonio; Mitchell Sutton; Michael D Escobar
Journal:  Sci Rep       Date:  2022-04-04       Impact factor: 4.379

3.  Seizure related injuries - Frequent injury patterns, hospitalization and therapeutic aspects.

Authors:  Nils Mühlenfeld; Philipp Störmann; Ingo Marzi; Felix Rosenow; Adam Strzelczyk; René D Verboket; Laurent M Willems
Journal:  Chin J Traumatol       Date:  2021-10-15

4.  [Inpatient treatment costs, cost-driving factors and potential reimbursement problems due to epileptic seizure-related injuries and fractures].

Authors:  René D Verboket; Nils Mühlenfeld; Jasmina Sterz; Philipp Störmann; Ingo Marzi; Yunus Balcik; Felix Rosenow; Adam Strzelczyk; Laurent M Willems
Journal:  Chirurg       Date:  2021-04       Impact factor: 0.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.